scispace - formally typeset
S

Simón Méndez-Ferrer

Researcher at University of Cambridge

Publications -  98
Citations -  9534

Simón Méndez-Ferrer is an academic researcher from University of Cambridge. The author has contributed to research in topics: Stem cell & Bone marrow. The author has an hindex of 33, co-authored 84 publications receiving 7997 citations. Previous affiliations of Simón Méndez-Ferrer include Centro Nacional de Investigaciones Cardiovasculares & Icahn School of Medicine at Mount Sinai.

Papers
More filters
Journal ArticleDOI

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

TL;DR: It is demonstrated that mesenchymal stem cells (MSCs), identified using nestin expression, constitute an essential HSC niche component and are indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs.
Journal ArticleDOI

Haematopoietic stem cell release is regulated by circadian oscillations

TL;DR: Circadian oscillations are markedly altered when mice are subjected to continuous light or to a ‘jet lag’ (defined as a shift of 12 h) and data indicate that a circadian, neurally driven release of HSC during the animal’s resting period may promote the regeneration of the stem cell niche and possibly other tissues.
Journal ArticleDOI

Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands

TL;DR: It is demonstrated that low concentrations of Toll-like receptor (TLR) ligands in the bloodstream drive CCR2-dependent emigration of monocytes from bone marrow and that bone marrow MSCs and CAR cells respond to circulating microbial molecules and regulate bloodstream monocyte frequencies by secreting MCP1 in proximity to bone marrow vascular sinuses.
Journal ArticleDOI

Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms

TL;DR: The results demonstrate that mutant-HSC-driven niche damage critically contributes to disease manifestation in MPN and identify niche-forming MSCs and their neural regulation as promising therapeutic targets.